Light Therapy News and Research

RSS

Light Therapy is the treatment of disease with certain types of light. Light therapy can use lasers, LED, fluorescent lamps, and ultraviolet or infrared radiation. Also called phototherapy.

Over 325 new Xist Fitness centers to be introduced across the U.S.

St. Louis' own BAM Brands, the parent company of Tanco, MassageLuXe and Xist Fitness will be introducing over 325 NEW Xist Fitness locations across the United States. Partnering with former Major League Baseball professional and 2015 Hall of Fame Nominee, Gary Sheffield, Xist Fitness will open approximately two hundred locations in Florida alone.

7 Dec 2014

Bright daylight could trigger panic attack

Fear of bright daylight is associated with panic disorder, according to new presented at the ECNP congress in Berlin.

21 Oct 2014

News Dispatch readers select Planet Fitness as #1 health club in Michigan City

Planet Fitness, the innovative health club franchise known for its Judgement Free Zone and affordable prices, was voted the #1 health club in Michigan City by News Dispatch readers.

26 Sep 2014

BioPhotas launches Celluma ELITE for sale to Aesthetic Physician Market

BioPhotas, Inc. today announced the launch of the Celluma ELITE for sale to the Aesthetic Physician Market. The LED therapy device is stand-mounted and able to be precisely positioned over an area of treatment via an articulating arm and a patented shape-taking light panel.

2 Sep 2014

Penn receives $8 million grant from NCI to study effects of PDT

Researchers at the Perelman School of Medicine at the University of Pennsylvania in collaboration with the Roswell Park Cancer Institute have received an $8 million grant from the National Cancer Institute (NCI) to study the effects of photodynamic light therapy (PDT) in patients with malignant pleural mesothelioma, a rare, aggressive and deadly cancer that most often manifests itself in the lining of the lungs and is caused almost exclusively by exposure to asbestos.

10 Jul 2014

Researchers receive $8 million NCI grant to study effects of PDT in patients with mesothelioma

Researchers at the Perelman School of Medicine at the University of Pennsylvania in collaboration with the Roswell Park Cancer Institute have received an $8 million grant from the National Cancer Institute to study the effects of photodynamic light therapy (PDT) in patients with malignant pleural mesothelioma, a rare, aggressive and deadly cancer that most often manifests itself in the lining of the lungs and is caused almost exclusively by exposure to asbestos.

10 Jul 2014

Noninvasive laser therapy triggers stem cells to repair enamel of teeth

A Harvard-led team is the first to demonstrate the ability to use low-power light to trigger stem cells inside the body to regenerate tissue, an advance they reported in Science Translational Medicine.

29 May 2014

Janssen submits sNDA to FDA for simeprevir in combination with sofosbuvir for treatment of HCV genotype 1 infection

Janssen Research & Development, LLC (Janssen) today announced it has submitted a Supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for simeprevir, an NS3/4A protease inhibitor marketed as OLYSIO™ in the United States, in combination with the nucleotide analog NS5B polymerase inhibitor sofosbuvir developed by Gilead Sciences, Inc.

8 May 2014

Environmental stresses can help trigger depression in people vulnerable to SAD, post-holiday blues

The first Monday after the holidays can be a depressing time for people coping with a post-holiday letdown and a type of depression triggered by short days called seasonal affective disorder.

6 Jan 2014

‘First-line’ role for sleep deprivation in suicidal bipolar patients

Chronotherapy, involving total sleep deprivation and light therapy, brings about a rapid reduction in suicidality among patients with bipolar disorder experiencing a phase of major depression.

3 Jan 2014

Treating depression fails to reverse cognitive deficits in bipolar disorder

Successful treatment of depression with total sleep deprivation does not improve neuropsychologic deficits in bipolar patients, despite improving clinical symptoms, Italian researchers report.

24 Dec 2013

FDA approves OLYSIO (simeprevir) for treatment of chronic hepatitis C infection

Janssen Therapeutics, Division of Janssen Products, LP, announced today the U.S. Food and Drug Administration has approved OLYSIO (simeprevir), an NS3/4A protease inhibitor, for the treatment of chronic hepatitis C infection as part of an antiviral treatment regimen in combination with pegylated interferon and ribavirin in genotype 1 infected adults with compensated liver disease, including cirrhosis.

23 Nov 2013

Study on women's preferences, decision-making patterns regarding treatment for depression during, after pregnancy

Women with depression in the perinatal period experience a high degree of conflict in deciding whether and how to treat their depression, but strongly prefer treatments other than antidepressant medications, reports a study in the November Journal of Psychiatric Practice®. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

19 Nov 2013

Delaying umbilical cord clamping after birth benefits newborn babies

Delaying clamping of the umbilical cord after birth benefits newborn babies, according to a systematic review published in The Cochrane Library. The authors found babies’ blood and iron levels were healthier when the cord was clamped later.

12 Jul 2013

Study suggests bright light therapy may improve sleep and brain function post mild TBI

A new study suggests that bright light therapy may improve sleep, cognition, emotion and brain function following mild traumatic brain injury (TBI).

1 Jun 2013

Northwestern Medicine expert offers tips to battle seasonal affective disorder

Winter is in full force. With short days and less exposure to sunlight, everyone feels less energetic and more people are vulnerable to depression. Seasonal Affective Disorder (SAD), or winter depression, is a mood disorder related to seasonal variations of light. Symptoms start in late fall and oftentimes last until April or early spring. It affects between 10 to 20 percent of Americans, primarily younger adults and women.

10 Feb 2013

NuFACE receives FDA clearance for Trinity Facial Toning Device

NuFACE is thrilled to announce the launch the FDA cleared Trinity Wrinkle Remover, a red light attachment for the NuFACE Trinity Facial Toning Device. The removable attachment is engineered with advanced LEDs to deliver a precise combination of red and infrared light therapy treatments to reduce full face wrinkles.

29 Nov 2012